Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: Randomized, two-arm, phase 2 trial
2025 · Cell Reports Medicine · 16 citations
https://doi.org/10.1016/j.xcrm.2025.101930
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
107
Citations
6
h-index
5
i10-index
Yu-Tong Liu is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune cells in cancer & Cell Adhesion Molecules Research. The author has an h-index of 6, co-authored 12 publications.
Papers by this author
worksSynthetic lethal CRISPR screen identifies a cancer cell-intrinsic role of PD-L1 in regulation of vulnerability to ferroptosis
2024 · Cell Reports · 10 citations
https://doi.org/10.1016/j.celrep.2024.114477
USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity
2025 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-025-59621-5
Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma
2025 · Cell Reports Medicine · 7 citations
https://doi.org/10.1016/j.xcrm.2025.102024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat